DIA Bioventure Day

28 March 2017, Crown Plaza Glasgow, UK

Where is Innovation in Health Care heading?


By Holger Adelmann, DIA EMEA

Is Europe geared up to provide an infrastructure to nurture Biotechs? The European Biotechnology Enterprises (EBE) has done a very critical assessment! Is the Pharma sector still attractive for investors or is IT largely eating in? Do we need innovative funding models?

Read more …

Follow Holger on Twitter and LinkedIn for the latest articles

In collaboration with